The PE Ratio as of September 2024 (TTM) for BioNTech SE (BNTX) is -38.27

According to BioNTech SE’s latest financial reports and current stock price. The company's current PE Ratio is -38.27. This represents a change of -631.38% compared to the average of 7.20 of the last 4 quarters.

BioNTech SE (BNTX) Historical PE Ratio (quarterly & annually)

How has BNTX PE Ratio performed in the past?

The mean historical PE Ratio of BioNTech SE over the last ten years is 117.64. The current -38.27 PE Ratio has changed -3353.23% with respect to the historical average. Over the past ten years (40 quarters), BNTX's PE Ratio was at its highest in in the September 2023 quarter at 38.33. The PE Ratio was at its lowest in in the December 2018 quarter at -520.89.

BioNTech SE (BNTX) PE Ratio by Quarter and Year

Discovering the peaks and valleys of BioNTech SE PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

BioNTech SE (BNTX) Average PE Ratio

How has BNTX PE Ratio performed in the past?

The current PE Ratio of BioNTech SE (BNTX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

BioNTech SE (BNTX) PE Ratio vs. Peers

How is BNTX’s PE Ratio compared to its peers?

BioNTech SE’s PE Ratio is less than Novavax, Inc. (-5.86), less than CohBar, Inc. (-0.20), less than Ginkgo Bioworks Holdings, Inc. (-0.32), less than CRISPR Therapeutics AG (-14.26), less than Ocean Biomedical, Inc. (0), less than Enveric Biosciences, Inc. (-0.17), less than Hepion Pharmaceuticals, Inc. (-0.36), less than Elevation Oncology, Inc. (-0.15), less than AVROBIO, Inc. (-0.93), less than PTC Therapeutics, Inc. (2.07), less than Krystal Biotech, Inc. (-5.05), less than Sarepta Therapeutics, Inc. (49.72), less than Iovance Biotherapeutics, Inc. (257.91), less than Madrigal Pharmaceuticals, Inc. (-6.48), less than null (-10.23),

Build a custom stock screener for BioNTech SE (BNTX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like BioNTech SE using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

BioNTech SE (BNTX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like BioNTech SE or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.